SALVANA SINGH
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care EDISON, NJ NPI 1982161972
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care NJ GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$549.28
- Category: General Payments
- Program years: PY2021–2024
- Record count: 35
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $118.88 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $118.88 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $32.33 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $30.62 | 2 |
| Abbott Laboratories | $22.84 | 1 |
| Relypsa, Inc. | $16.78 | 1 |
| Amgen Inc. | $16.31 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1116540199 | GlaxoSmithKline, LLC. | $15.83 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116583349 | GlaxoSmithKline, LLC. | $16.50 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117685520 | Amgen Inc. | $16.31 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124061688 | Vifor Pharma, Inc. | $16.78 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125368658 | Abbott Laboratories | $22.84 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141509281 | CALLIDITAS THERAPEUTICS US INC. | $15.62 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141520727 | CALLIDITAS THERAPEUTICS US INC. | $15.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.